Ascentage Pharma Group International Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Ascentage Pharma Group International - Alpha Spread

Ascentage Pharma Group International
HKEX:6855

Watchlist Manager
Ascentage Pharma Group International Logo
Ascentage Pharma Group International
HKEX:6855
Watchlist
Price: 41.35 HKD -1.43% Market Closed
Market Cap: 13B HKD
Have any thoughts about
Ascentage Pharma Group International?
Write Note

Wall Street
Price Targets

Price Targets Summary
Ascentage Pharma Group International

Wall Street analysts forecast Ascentage Pharma Group International stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 40.12 HKD with a low forecast of 37.37 HKD and a high forecast of 43.05 HKD.

Lowest
Price Target
37.37 HKD
10% Downside
Average
Price Target
40.12 HKD
3% Downside
Highest
Price Target
43.05 HKD
4% Upside
Ascentage Pharma Group International Competitors:
Price Targets
CPRX
Catalyst Pharmaceuticals Inc
53% Upside
ACLX
Arcellx Inc
3% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
97% Upside
ITOS
Iteos Therapeutics Inc
300% Upside
PHIL
Philogen SpA
20% Upside
RCEL
AVITA Medical Inc
53% Upside
CYTK
Cytokinetics Inc
51% Upside
EXAI
Exscientia PLC
13% Upside

Revenue
Forecast

Revenue Estimate
Ascentage Pharma Group International

For the last 6 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 81%. The projected CAGR for the next 3 years is 80%.

81%
Past Growth
80%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascentage Pharma Group International

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Ascentage Pharma Group International's stock price target?
Price Target
40.12 HKD

According to Wall Street analysts, the average 1-year price target for Ascentage Pharma Group International is 40.12 HKD with a low forecast of 37.37 HKD and a high forecast of 43.05 HKD.

What is Ascentage Pharma Group International's Revenue forecast?
Projected CAGR
80%

For the last 6 years the compound annual growth rate for Ascentage Pharma Group International's revenue is 81%. The projected CAGR for the next 3 years is 80%.

Back to Top